nitroglycerin has been researched along with transforming growth factor beta in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clarkson, P; Crook, JR; Cummings, MH; Donald, A; Meeking, DR; Shaw, KM; Thorne, S; Watts, GF | 1 |
Chen, HJ; Li, DY; Mehta, JL | 1 |
Asadikaram, GA; Kazemi Arababadi, M; Kennedy, D; Kiani, Z; Kohan, F; Masoomi, M; Nasiri, AA; Ruzbehi, F; Sepehri, ZS; Sheikh Fathollahi, M | 1 |
3 other study(ies) available for nitroglycerin and transforming growth factor beta
Article | Year |
---|---|
Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria.
Topics: Adult; Albuminuria; Brachial Artery; Cholesterol, HDL; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hyperemia; Insulin; Ischemia; Male; Nitroglycerin; Transforming Growth Factor beta; Vasodilation; Vasodilator Agents | 1999 |
Protection of myocytes from hypoxia-reoxygenation injury by nitric oxide is mediated by modulation of transforming growth factor-beta1.
Topics: Animals; Cells, Cultured; Culture Media, Conditioned; Cytoprotection; Molsidomine; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Protein Kinase C; Rats; RNA, Messenger; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Comparison of serum levels of IL-6, IL-8, TGF-β and TNF-α in coronary artery diseases, stable angina and participants with normal coronary artery.
Topics: Angina, Stable; Case-Control Studies; Coronary Artery Disease; Coronary Vessels; Cross-Sectional Studies; Exercise; Female; Gene Expression; Humans; Interleukin-6; Interleukin-8; Iran; Male; Middle Aged; Nitroglycerin; Risk Factors; Smoking; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2018 |